The Federal Communications Commission (FCC) on Thursday took action to promote telehealth in rural America through reforms to the Rural Health Care Program that ensure limited program funds are disbursed efficiently and equitably, promote transparency and predictability in the program’s administration, and strengthen safeguards against waste, fraud, and abuse.
The announcement revises the rules governing the Telecom Program to simplify calculation of the urban rate—the amount health care
Read More
Diabetic Retinopathy
Can AI Transform Patient Care from Reactive Craft to Strategic Art?
Personalized Analytics is becoming essential in healthcare, stemming from the movement from fee-for-service to a value-based market. The need to preempt and prevent disease on a more personal level, rather than merely reacting to symptoms, has created a significant opportunity for machine learning-based applications. This “analytics of one” approach (using advanced mathematical models and artificial intelligence techniques) is already impacting several key areas:
1. Medical imaging is utilizing
Read More
IDx and Topcon Join Forces to Scale AI-based Diagnostic Platform in the U.S. Market
IDx, an AI diagnostics company, and Topcon, one of the world’s leading ophthalmic device manufacturers, have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the U.S. market. As part of the agreement, is granted exclusive rights to IDx-DR system, an autonomous AI system that instantly detects diabetic retinopathy in fundus images, exclusively with Topcon NW400, an easy to use, robotic fundus camera. IDx-DR is an FDA-cleared
Read More
Cox Health: Diabetic Retinopathy Telemedicine Improves HEDIS Quality Measures
CoxHealth, a Missouri-based health system and payer announced that it has improved its HEDIS quality measures using Intelligent Retinal Imaging Systems (IRIS) diabetic retinopathy telemedicine solution, according to a recent case study. For the case study, Cox Health administered the diabetic retinopathy exam (DRE) to 1,865 patients over an initial 100-day period, diagnosing 305 (16%) with diabetic retinopathy who otherwise would have gone undiagnosed.Case Study BackgroundWith approximately
Read More
